Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia

Aim: Lomitapide is an oral inhibitor of the microsomal triglyceride transfer protein used to treat homozygous familial hypercholesterolemia (HoFH); patients require a low-fat diet to minimize gastrointestinal adverse effects and dietary supplements to prevent nutrient deficiencies. We investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameyama, Noriko, Maruyama, Chizuko, Kitagawa, Fuyuha, Nishii, Kazunobu, Uenomachi, Kaori, Katayama, Yayoi, Koga, Hiromi, Chikamoto, Naoko, Kuwata, Yuko, Torigoe, Junko, Arimoto, Masako, Tokumaru, Toshiaki, Ikewaki, Katsunori, Nohara, Atsushi, Otsubo, Yoshihiko, Yanagi, Koji, Yoshida, Masayuki, Harada-Shiba, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308262/
https://www.ncbi.nlm.nih.gov/pubmed/29899183
http://dx.doi.org/10.5551/jat.44107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308262/
https://www.ncbi.nlm.nih.gov/pubmed/29899183
http://dx.doi.org/10.5551/jat.44107

Ejemplares similares